Key result
Community-acquired acute kidney injury was associated with a more than twofold increased risk of de novo heart failure hospitalization at 365 days compared with no CA-AKI (RR 2.16; 95% CI 1.77-2.64; p<0.001).
Why the study?
Although hospital-acquired AKI increases the risk for subsequent heart failure, little is known about the relation between community-acquired AKI and incident heart failure.
Does community-acquired acute kidney injury increase the risk of de novo heart failure hospitalization in adults without prior heart failure?
Cohort (n=210,895)
Does community-acquired acute kidney injury increase the risk of de novo heart failure hospitalization in adults without prior heart failure?
Community-acquired acute kidney injury is a significant risk factor for de novo heart failure hospitalization within 1 year, highlighting a potential opportunity for early intervention in primary care.
CA-AKI was associated with ~2-fold higher de novo HF hospitalization risk; leaves open whether monitoring or intervention alters outcomes.
OBJECTIVES: Because patients with hospital-acquired acute kidney injury (AKI) are at risk for subsequent development of heart failure (HF) and little is known about the relation between community-acquired AKI (CA-AKI) and HF, we sought to determine if CA-AKI is a risk factor for incident HF hospitalization. METHODS: We utilized Baylor Scott & White Health databases at the primary care and inpatient hospitalization levels to identify adults without a prior history of HF who had 2 or more serum creatinine measurements within 13 months in the primary care setting. We defined CA-AKI as a serum creatinine increase ≥0.3 mg/dL or ≥1.5 times the baseline for consecutive values within a 13-month period. We created a flag for de novo HF hospitalization at 90, 180, and 365 days following CA-AKI evaluation. RESULTS: In the analyses, 210,895 unique adults were included, of whom 5,358 (2.5%) had CA-AKI. Those with CA-AKI had higher rates of comorbidities, higher rate of males (48 vs. 42%, p < 0.001), and were older (61.5 [50.3, 73.1] vs. 54.1 [42.8, 64.7] years, p < 0.001) than those who did not have CA-AKI. In total, 607 (0.3%), 833 (0.4%), and 1,089 (0.5%) individuals had an incident HF hospitalization in the 90, 180, and 365 days following the CA-AKI evaluation, respectively. After adjusting for demographic and clinical characteristics, patients with CA-AKI had >2 times the risk of de novo HF hospitalization compared with patients who did not have CA-AKI (90 days: 2.35 [1.83-3.02], p < 0.001; 180 days: 2.52 [2.04-3.13], p < 0.001; 365 days: 2.16 [1.77-2.64], p < 0.001). These multivariable models yielded strong predictive abilities, with the areas under the receiver-operating characteristic curve >0.90. CONCLUSION: After controlling for baseline and clinical characteristics, patients with CA-AKI were at approximately twofold the risk of de novo HF hospitalization (within 90, 180, and 365 days) compared with those who did not have CA-AKI. Hence, detecting CA-AKI may provide an opportunity for early intervention at the primary care level to possibly delay HF development.
No takes yet. Share an insight, caveat, or question.
Tecson et al. (2019) conducted a cohort in Community-acquired acute kidney injury (n=210,895). Community-acquired acute kidney injury (CA-AKI) vs. No CA-AKI was evaluated on De novo heart failure hospitalization at 365 days (RR 2.16, 95% CI 1.77-2.64, p=<0.001). Community-acquired acute kidney injury was associated with a more than twofold increased risk of de novo heart failure hospitalization at 365 days compared with no CA-AKI (RR 2.16; 95% CI 1.77-2.64; p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: